Literature DB >> 8289245

Characterization of an in vitro-selected RNA ligand to the HIV-1 Rev protein.

K B Jensen1, L Green, S MacDougal-Waugh, C Tuerk.   

Abstract

A small RNA ligand with high affinity for the HIV-1 Rev protein, generated by the SELEX in vitro evolution method, was used in a series of chemical modification studies to aid in determining the secondary structure of the ligand, to detect which modifications interfere with the binding of the ligand to Rev, and to find those modifiable groups that are protected from attack when bound to the Rev protein. This SELEX RNA ligand, like the high-affinity binding site of the Rev-responsive element, seems to bind the Rev protein within or along the major groove. There are two major regions of the RNA that interact with the Rev protein, and these regions appear to be close in space. Additionally, this high-affinity ligand has been used as the basis for an additional "biased randomization" SELEX procedure, in an effort to gain comprehensive information on the RNA sequences and structural elements necessary for efficient binding to the Rev protein. This complementary experimental approach supports the structural conclusions of our chemical modification data.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8289245     DOI: 10.1016/s0022-2836(05)80030-0

Source DB:  PubMed          Journal:  J Mol Biol        ISSN: 0022-2836            Impact factor:   5.469


  15 in total

1.  Anti-Rex aptamers as mimics of the Rex-binding element.

Authors:  S Baskerville; M Zapp; A D Ellington
Journal:  J Virol       Date:  1999-06       Impact factor: 5.103

2.  Selections for constituting new RNA-protein interactions in catalytic RNP.

Authors:  Shota Atsumi; Yoshiya Ikawa; Hideaki Shiraishi; Tan Inoue
Journal:  Nucleic Acids Res       Date:  2003-01-15       Impact factor: 16.971

3.  In vitro selection of RNAs that bind to the human immunodeficiency virus type-1 gag polyprotein.

Authors:  M A Lochrie; S Waugh; D G Pratt; J Clever; T G Parslow; B Polisky
Journal:  Nucleic Acids Res       Date:  1997-07-15       Impact factor: 16.971

4.  The neuronal RNA binding protein Nova-1 recognizes specific RNA targets in vitro and in vivo.

Authors:  R J Buckanovich; R B Darnell
Journal:  Mol Cell Biol       Date:  1997-06       Impact factor: 4.272

5.  Using in vitro selection to direct the covalent attachment of human immunodeficiency virus type 1 Rev protein to high-affinity RNA ligands.

Authors:  K B Jensen; B L Atkinson; M C Willis; T H Koch; L Gold
Journal:  Proc Natl Acad Sci U S A       Date:  1995-12-19       Impact factor: 11.205

6.  NMR evidence for a base triple in the HIV-2 TAR C-G.C+ mutant-argininamide complex.

Authors:  A S Brodsky; H A Erlacher; J R Williamson
Journal:  Nucleic Acids Res       Date:  1998-04-15       Impact factor: 16.971

7.  Mutations that confer resistance to template-analog inhibitors of human immunodeficiency virus (HIV) type 1 reverse transcriptase lead to severe defects in HIV replication.

Authors:  Timothy S Fisher; Pheroze Joshi; Vinayaka R Prasad
Journal:  J Virol       Date:  2002-04       Impact factor: 5.103

8.  RNA ligands to human nerve growth factor.

Authors:  J Binkley; P Allen; D M Brown; L Green; C Tuerk; L Gold
Journal:  Nucleic Acids Res       Date:  1995-08-25       Impact factor: 16.971

9.  Methylphosphonate mapping of phosphate contacts critical for RNA recognition by the human immunodeficiency virus tat and rev proteins.

Authors:  C E Pritchard; J A Grasby; F Hamy; A M Zacharek; M Singh; J Karn; M J Gait
Journal:  Nucleic Acids Res       Date:  1994-07-11       Impact factor: 16.971

10.  Structural probing and damage selection of citrulline- and arginine-specific RNA aptamers identify base positions required for binding.

Authors:  P Burgstaller; M Kochoyan; M Famulok
Journal:  Nucleic Acids Res       Date:  1995-12-11       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.